EGFR and non-small cell lung carcinoma: In specific, the immune metabolic reprograming mediated by adenosine signaling in TME is reported as a further hallmark of EGFR-mutated NSCLC, with the precise aim to evade the immune surveillance and induce innate immune resistance to ICIs (19).